Results 201 to 210 of about 5,266 (226)

The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; A randomized clinical trial study

ARYA Atherosclerosis, 2019
BACKGROUND Previous studies have proved that intracoronary injection of eptifibatide is safe and more effective in infarct size reduction and clinical outcomes than intravenously injection in the patients with acute myocardial infarction (AMI).
Abdullatef Ghazal, H. Shemirani, A. Amirpour, M. Kermani-Alghoraishi   +3 more
semanticscholar   +1 more source

PEGylated PAMAM Dendrimers as Eptifibatide Nanocarriers: An Atomistic View from Molecular Dynamics Simulations

Chemical Engineering and Science, 2022
Farideh Badalkhani-Khamseh, A. Ebrahim-Habibi, N. Hadipour, M. Behmanesh   +3 more
semanticscholar   +1 more source

Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial.

Revista Española de Cardiología, 2022
M. Hamza, I. Elgendy
semanticscholar   +1 more source

Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies

Journal of Thrombosis and Thrombolysis, 2021
Jingting Liu, Yihong Yang, Hongbo Liu
semanticscholar   +1 more source

The role of eptifibatide in patients undergoing percutaneous coronary intervention

Expert Opinion on Pharmacotherapy, 2007
Glycoprotein (GP) IIb/IIIa receptor antagonists inhibit the binding of ligands to activated platelet GP IIb/IIIa receptors and, therefore, prevent the formation of platelet thrombi. They have been extensively studied in patients undergoing percutaneous coronary intervention (PCI).
openaire   +3 more sources

Surface modification of polyurethane with eptifibatide-loaded degradable nanoparticles reducing risk of blood coagulation.

Colloids and Surfaces B: Biointerfaces, 2021
K. Reczyńska, R. Major, M. Kopernik, E. Pamuła, G. Imbir, H. Plutecka, F. Bruckert, M. Surmiak   +7 more
semanticscholar   +1 more source

Eptifibatide/verapamil

Reactions weekly, 2021

semanticscholar   +1 more source

Association of eptifibatide and acute profound thrombocytopenia

The American Journal of Cardiology, 2001
Bruce N. Brent, Richard Hongo
openaire   +3 more sources

Eptifibatide

Reactions weekly, 2021

semanticscholar   +1 more source

Eptifibatide in Acute Coronary Syndromes

New England Journal of Medicine, 1999
openaire   +3 more sources